Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;90:1688-1695

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bostom, A. G.
Right arrow Articles by Castelli, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bostom, A. G.
Right arrow Articles by Castelli, W. P.

Circulation, Vol 90, 1688-1695, Copyright © 1994 by American Heart Association


ARTICLES

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

AG Bostom, DR Gagnon, LA Cupples, PW Wilson, JL Jenner, JM Ordovas, EJ Schaefer and WP Castelli
Framingham Heart Study, MA 01701.

BACKGROUND: Sinking prebeta lipoprotein is a putative marker for elevated levels of lipoprotein (a). Although prospective data suggest that increased plasma lipoprotein (a) is an independent risk factor for coronary heart disease in men, no prospective studies are available in women. METHODS AND RESULTS: From 1968 through 1975, sinking prebeta lipoprotein was determined by paper electrophoresis in 3103 women Framingham Heart Study participants who were free of prevalent cardiovascular disease. A sinking prebeta lipoprotein band was detectable in 434 of the women (14%) studied. The median follow-up interval was approximately 12 years. Incident cardiovascular disease was associated with band presence using a proportional hazards model that included age, smoking, body mass index, systolic blood pressure, glucose intolerance, low- and high-density lipoprotein cholesterol, and ECG left ventricular hypertrophy. Multivariable adjusted relative risk estimates (with 95% confidence intervals) for outcomes in the band present versus absent groups were as follows: myocardial infarction (82 events), 2.37 (1.48 to 3.81); intermittent claudication (62 events), 1.94 (1.07 to 3.50); cerebrovascular disease (83 events), 1.88 (1.12 to 3.15); total coronary heart disease (174 events), 1.61 (1.13 to 2.29); and total cardiovascular disease (305 events), 1.44 (1.09 to 1.91). A subset analysis indicated that band presence was 50.9% sensitive and 95.4% specific for detecting plasma lipoprotein (a) levels of > 30 mg/dL, the threshold value linked to increased cardiovascular disease risk in men. CONCLUSIONS: Sinking prebeta lipoprotein was a valid surrogate for elevated lipoprotein (a) levels in Framingham Heart Study women. Band presence and, equivalently, elevated plasma lipoprotein (a), was a strong, independent predictor of myocardial infarction, intermittent claudication, and cerebrovascular disease. Confirmation of these findings in other longitudinal studies of women is needed.


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
M. Helfand, D. I. Buckley, M. Freeman, R. Fu, K. Rogers, C. Fleming, and L. L. Humphrey
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
Ann Intern Med, October 6, 2009; 151(7): 496 - 507.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
The Emerging Risk Factors Collaboration
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA, July 22, 2009; 302(4): 412 - 423.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Suk Danik, N. Rifai, J. E. Buring, and P. M. Ridker
Lipoprotein(a), Hormone Replacement Therapy, and Risk of Future Cardiovascular Events
J. Am. Coll. Cardiol., July 8, 2008; 52(2): 124 - 131.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Bennet, E. Di Angelantonio, S. Erqou, G. Eiriksdottir, G. Sigurdsson, M. Woodward, A. Rumley, G. D. O. Lowe, J. Danesh, and V. Gudnason
Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease: Large-Scale Prospective Data
Arch Intern Med, March 24, 2008; 168(6): 598 - 608.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. D. Pradhan, S. Shrivastava, N. R. Cook, N. Rifai, M. A. Creager, and P. M Ridker
Symptomatic Peripheral Arterial Disease in Women: Nontraditional Biomarkers of Elevated Risk
Circulation, February 12, 2008; 117(6): 823 - 831.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Smolders, R. Lemmens, and V. Thijs
Lipoprotein (a) and Stroke: A Meta-Analysis of Observational Studies
Stroke, June 1, 2007; 38(6): 1959 - 1966.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. Suk Danik, N. Rifai, J. E. Buring, and P. M Ridker
Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
JAMA, September 20, 2006; 296(11): 1363 - 1370.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Ohira, P. J. Schreiner, J. D. Morrisett, L. E. Chambless, W. D. Rosamond, and A. R. Folsom
Lipoprotein(a) and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
Stroke, June 1, 2006; 37(6): 1407 - 1412.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Rubin, H. J. Kim, T. A. Pearson, S. Holleran, R. Ramakrishnan, and L. Berglund
Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a]
J. Lipid Res., May 1, 2006; 47(5): 982 - 989.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Bittner
Perspectives on Dyslipidemia and Coronary Heart Disease in Women
J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1628 - 1635.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
I. Shai, E. B. Rimm, S. E. Hankinson, C. Cannuscio, G. Curhan, J. E. Manson, N. Rifai, M. J. Stampfer, and J. Ma
Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?
Eur. Heart J., August 2, 2005; 26(16): 1633 - 1639.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. McGovern
Niaspan(R): creating a new concept for raising HDL-cholesterol
Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F41 - F47.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Berglund and R. Ramakrishnan
Lipoprotein(a): An Elusive Cardiovascular Risk Factor
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2219 - 2226.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. A. Ariyo, C. Thach, R. Tracy, and the Cardiovascular Health Study Investigators
Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly
N. Engl. J. Med., November 27, 2003; 349(22): 2108 - 2115.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. J. Davies, J. T. Judd, D. J. Baer, B. A. Clevidence, D. R. Paul, A. J. Edwards, S. A. Wiseman, R. A. Muesing, and S. C. Chen
Black Tea Consumption Reduces Total and LDL Cholesterol in Mildly Hypercholesterolemic Adults
J. Nutr., October 1, 2003; 133(10): 3298S - 3302.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. R. Holmer, C. Hengstenberg, H.-G. Kraft, B. Mayer, M. Poll, S. Kurzinger, M. Fischer, H. Lowel, G. Klein, G. A.J. Riegger, et al.
Association of Polymorphisms of the Apolipoprotein(a) Gene With Lipoprotein(a) Levels and Myocardial Infarction
Circulation, February 11, 2003; 107(5): 696 - 701.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Peltier, M. C. Iannetta Peltier, M. E. Sarano, J.-P. M. Lesbre, J.-L. Colas, and C. M. Tribouilloy
Elevated Serum Lipoprotein(a) Level Is an Independent Marker of Severity of Thoracic Aortic Atherosclerosis*
Chest, May 1, 2002; 121(5): 1589 - 1594.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. E Roeters van Lennep, H.T. Westerveld, D.W. Erkelens, and E. E van der Wall
Risk factors for coronary heart disease: implications of gender
Cardiovasc Res, February 15, 2002; 53(3): 538 - 549.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Rubin, F. Paultre, C. H. Tuck, S. Holleran, R. G. Reed, T. A. Pearson, C. M. Thomas, R. Ramakrishnan, and L. Berglund
Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians
J. Lipid Res., February 1, 2002; 43(2): 234 - 244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. J Schaefer
Lipoproteins, nutrition, and heart disease
Am. J. Clinical Nutrition, February 1, 2002; 75(2): 191 - 212.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Rubin, T. A. Pearson, R. G. Reed, and L. Berglund
Fluorescence-based, Nonradioactive Method for Efficient Detection of the Pentanucleotide Repeat (TTTTA)n Polymorphism in the Apolipoprotein(a) Gene
Clin. Chem., October 1, 2001; 47(10): 1758 - 1762.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. M. Simo, J. Camps, E. Vilella, F. Gomez, A. Paul, and J. Joven
Instability of Lipoprotein(a) in Plasma Stored at -70 {degrees}C : Effects of Concentration, Apolipoprotein(a) Genotype, and Donor Cardiovascular Disease
Clin. Chem., September 1, 2001; 47(9): 1673 - 1678.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Sarti, L. Pantoni, G. Pracucci, A. Di Carlo, P. Vanni, and D. Inzitari
Lipoprotein(a) and Cognitive Performances in an Elderly White Population : Cross-Sectional and Follow-Up Data
Stroke, July 1, 2001; 32(7): 1678 - 1683.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
Y. Cui, R. S. Blumenthal, J. A. Flaws, M. K. Whiteman, P. Langenberg, P. S. Bachorik, and T. L. Bush
Non-High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
Arch Intern Med, June 11, 2001; 161(11): 1413 - 1419.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Ricci, G. Tamaro, R. Simeone, E. Giolo, G. Nucera, F. De Seta, and S. Guaschino
Lipoprotein(a) changes during natural menstrual cycle and ovarian stimulation with recombinant and highly purified urinary FSH
Hum. Reprod., March 1, 2001; 16(3): 449 - 456.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
T. J. Tegos, E. Kalodiki, M. M. Sabetai, and A. N. Nicolaides
The Genesis of Atherosclerosis and Risk Factors: A Review
Angiology, February 1, 2001; 52(2): 89 - 98.
[Abstract] [PDF]


Home page
Eur Heart JHome page
W.D Ashton, K Nanchahal, and D.A Wood
Body mass index and metabolic risk factors for coronary heart disease in women
Eur. Heart J., January 1, 2001; 22(1): 46 - 55.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Paultre, T. A. Pearson, H. F. C. Weil, C. H. Tuck, M. Myerson, J. Rubin, C. K. Francis, H. F. Marx, E. F. Philbin, R. G. Reed, et al.
High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men
Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2619 - 2624.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
T. J. Tegos, E. Kalodiki, S.-S. Daskalopoulou, and A. N. Nicolaides
Stroke: Epidemiology, Clinical Picture, and Risk Factors: Part I of III
Angiology, October 1, 2000; 51(10): 793 - 808.
[Abstract] [PDF]


Home page
CirculationHome page
J. Danesh, R. Collins, and R. Peto
Lipoprotein(a) and Coronary Heart Disease : Meta-Analysis of Prospective Studies
Circulation, September 5, 2000; 102(10): 1082 - 1085.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. G. Shlipak, J. A. Simon, E. Vittinghoff, F. Lin, E. Barrett-Connor, R. H. Knopp, R. I. Levy, and S. B. Hulley
Estrogen and Progestin, Lipoprotein(a), and the Risk of Recurrent Coronary Heart Disease Events After Menopause
JAMA, April 12, 2000; 283(14): 1845 - 1852.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Nishino, M. J. Malloy, J. Naya-Vigne, J. Russell, J. P. Kane, and R. F. Redberg
Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women
J. Am. Coll. Cardiol., February 1, 2000; 35(2): 314 - 320.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. M. Foody, J. A. Milberg, K. Robinson, G. L. Pearce, D. W. Jacobsen, and D. L. Sprecher
Homocysteine and Lipoprotein(a) Interact to Increase CAD Risk in Young Men and Women
Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 493 - 499.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
K. J. Harjai
Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen
Ann Intern Med, September 7, 1999; 131(5): 376 - 386.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. J. Seman, C. DeLuca, J. L. Jenner, L. A. Cupples, J. R. McNamara, P. W.F. Wilson, W. P. Castelli, J. M. Ordovas, and E. J. Schaefer
Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study
Clin. Chem., July 1, 1999; 45(7): 1039 - 1046.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. R. Kaseta, D. F. Skafar, J. L. Ram, S. J. Jacober, and J. R. Sowers
Cardiovascular Disease in the Diabetic Woman
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1835 - 1838.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
F. KRONENBERG, U. NEYER, K. LHOTTA, E. TRENKWALDER, M. AUINGER, A. PRIBASNIG, T. MEISL, P. KÖNIG, and H. DIEPLINGER
The Low Molecular Weight Apo(a) Phenotype Is an Independent Predictor for Coronary Artery Disease in Hemodialysis Patients: A ProspectiveFollow-Up
J. Am. Soc. Nephrol., May 1, 1999; 10(5): 1027 - 1036.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
K. Nilausen and H. Meinertz
Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein
Am. J. Clinical Nutrition, March 1, 1999; 69(3): 419 - 425.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Pahor, M. B. Elam, R. J. Garrison, S. B. Kritchevsky, and W. B. Applegate
Emerging Noninvasive Biochemical Measures to Predict Cardiovascular Risk
Arch Intern Med, February 8, 1999; 159(3): 237 - 245.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
W. Y. Craig, L. M. Neveux, G. E. Palomaki, M. M. Cleveland, and J. E. Haddow
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies
Clin. Chem., November 1, 1998; 44(11): 2301 - 2306.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. Su, H. Campos, H. Judge, B. W. Walsh, and F. M. Sacks
Metabolism of Apo(a) and ApoB100 of Lipoprotein(a) in Women: Effect of Postmenopausal Estrogen Replacement
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3267 - 3276.
[Abstract] [Full Text]


Home page
CirculationHome page
M. A. Espeland, S. M. Marcovina, V. Miller, P. D. Wood, C. Wasilauskas, R. Sherwin, H. Schrott, and T. L. Bush
Effect of Postmenopausal Hormone Therapy on Lipoprotein(a) Concentration
Circulation, March 17, 1998; 97(10): 979 - 986.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. N. Hopkins, L. L. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams
Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2783 - 2792.
[Abstract] [Full Text]


Home page
CirculationHome page
T. T. Nguyen, R. D. Ellefson, D. O. Hodge, K. R. Bailey, T. E. Kottke, and H. S. Abu-Lebdeh
Predictive Value of Electrophoretically Detected Lipoprotein(a) for Coronary Heart Disease and Cerebrovascular Disease in a Community-Based Cohort of 9936 Men and Women
Circulation, September 2, 1997; 96(5): 1390 - 1397.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. A. Clevidence, J. T. Judd, E. J. Schaefer, J. L. Jenner, A. H. Lichtenstein, R. A. Muesing, J. Wittes, and M. E. Sunkin
Plasma Lipoprotein (a) Levels in Men and Women Consuming Diets Enriched in Saturated, Cis-, or Trans-Monounsaturated Fatty Acids
Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1657 - 1661.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. R. Zysow, K. Kauser, R. M. Lawn, and G. M. Rubanyi
Effects of Estrus Cycle, Ovariectomy, and Treatment with Estrogen, Tamoxifen, and Progesterone on Apolipoprotein(a) Gene Expression in Transgenic Mice
Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1741 - 1745.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
P. W. F. Wilson and W. B. Kannel
Should We Measure Lipoprotein Lp(a)?
Arch Intern Med, June 9, 1997; 157(11): 1161 - 1162.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
J. H. Stein and R. S. Rosenson
Lipoprotein Lp(a) Excess and Coronary Heart Disease
Arch Intern Med, June 9, 1997; 157(11): 1170 - 1176.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. H. Wild, S. P. Fortmann, and S. M. Marcovina
A Prospective Case-Control Study of Lipoprotein(a) Levels and Apo(a) Size and Risk of Coronary Heart Disease in Stanford Five-City Project Participants
Arterioscler Thromb Vasc Biol, February 1, 1997; 17(2): 239 - 245.
[Abstract] [Full Text]


Home page
CirculationHome page
K. Orth-Gomer, M. A. Mittleman, K. Schenck-Gustafsson, S. P. Wamala, M. Eriksson, K. Belkic, R. Kirkeeide, B. Svane, and L. Ryden
Lipoprotein(a) as a Determinant of Coronary Heart Disease in Young Women
Circulation, January 21, 1997; 95(2): 329 - 334.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Kronenberg, E. Trenkwalder, H. Dieplinger, and G. Utermann
Lipoprotein(a) in Stored Plasma Samples and the Ravages of Time: Why Epidemiological Studies Might Fail
Arterioscler Thromb Vasc Biol, December 1, 1996; 16(12): 1568 - 1572.
[Abstract] [Full Text]


Home page
CirculationHome page
S. Sunayama, H. Daida, H. Mokuno, H. Miyano, H. Yokoi, Y. J. Lee, H. Sakurai, and H. Yamaguchi
Lack of Increased Coronary Atherosclerotic Risk Due to Elevated Lipoprotein(a) in Women >=55 Years of Age
Circulation, September 15, 1996; 94(6): 1263 - 1268.
[Abstract] [Full Text]


Home page
JAMAHome page
A. G. Bostom, L. A. Cupples, J. L. Jenner, J. M. Ordovas, L. J. Seman, P. W. F. Wilson, E. J. Schaefer, and W. P. Castelli
Elevated Plasma Lipoprotein(a) and Coronary Heart Disease in Men Aged 55 Years and Younger: A Prospective Study
JAMA, August 21, 1996; 276(7): 544 - 548.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Tonstad, O. Joakimsen, E. Stensland-Bugge, T. P. Leren, L. Ose, D. Russell, and K. H. Bonaa
Risk Factors Related to Carotid Intima-Media Thickness and Plaque in Children With Familial Hypercholesterolemia and Control Subjects
Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 984 - 991.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
R. S. Rosenson
Beyond Low-Density Lipoprotein Cholesterol: A Perspective on Low High-Density Lipoprotein Disorders and Lp(a) Lipoprotein Excess
Arch Intern Med, June 24, 1996; 156(12): 1278 - 1284.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. L. Hoover-Plow, N. Boonmark, P. Skocir, R. Lawn, and E. F. Plow
A Quantitative Immunoassay for the Lysine-Binding Function of Lipoprotein(a) : Application to Recombinant Apo(a) and Lipoprotein(a) in Plasma
Arterioscler Thromb Vasc Biol, May 1, 1996; 16(5): 656 - 664.
[Abstract] [Full Text]


Home page
JAMAHome page
W. Y. Craig and A. G. Bostom
Lipoprotein(a) Concentration and Risk of Atherothrombotic Disease
JAMA, October 18, 1995; 274(15): 1198 - 1198.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Lawn, N. W. Boonmark, K. Schwartz, G. E. Lindahl, D. P. Wade, C. D. Byrne, K. J. Fong, K. Meer, and L. Patthy
The Recurring Evolution of Lipoprotein(a)
J. Biol. Chem., October 13, 1995; 270(41): 24004 - 24009.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. M. Ridker, M. J. Stampfer, and C. H. Hennekens
Plasma Concentration of Lipoprotein(a) and the Risk of Future Stroke
JAMA, April 26, 1995; 273(16): 1269 - 1273.
[Abstract] [PDF]


Home page
CirculationHome page
E. Haber
Angiotensin-Converting Enzyme and Lipoprotein(a) as Risk Factors for Myocardial Infarction
Circulation, March 15, 1995; 91(6): 1888 - 1890.
[Full Text]